New Treatments for Newly Diagnosed MM Offer a Lot of Benefit, but Key Knowledge Gaps Remain

While there is, rightfully, a lot of optimism around the latest treatments for newly diagnosed multiple myeloma, not everyone is gaining the same benefit, said Kenneth Shain, MD, PhD, of H. Lee Moffitt Cancer Center.

Related Keywords

United States ,American ,Kenneth Shain ,Pentecost Myeloma Research Center ,H Lee Moffitt Cancer Center Kenneth Shain ,H Lee Moffitt Cancer Center ,Moffitt Cancer Center ,Malignant Hematology ,Chemical Biology ,Molecular Medicine ,Moffitt Cancer ,American Journal ,Managed Care ,